|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 1.96B 1.75B 1.62B 1.46B 2.76B 185B 2.79B 19.39B 7.61B 97.24B 7.35B 7.2B 310B | P/E 2026 * |
6.24x | P/E 2027 * | 81.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.72B 1.53B 1.42B 1.28B 2.41B 162B 2.44B 16.98B 6.66B 85.12B 6.44B 6.3B 271B | EV / Sales 2026 * |
0.94x | EV / Sales 2027 * | 0.97x |
| Free-Float |
94.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sarepta Therapeutics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Severino
CEO | Chief Executive Officer | 60 | 2026-07-27 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 2025-07-15 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 2020-12-13 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 2015-04-15 |
| Director/Board Member | 87 | 2010-05-31 | |
Rick Barry
BRD | Director/Board Member | 67 | 2015-06-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| -0.57% | +2.50% | +38.75% | +63.84% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.79% | +1.46% | +21.82% | +51.17% | 292B | |
| +0.47% | -0.25% | +1.00% | +25.41% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | +0.38% | +3.22% | +35.37% | +69.07% | 443.11B | |
| Weighted average by Cap. | +0.67% | +3.73% | +40.78% | +79.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.83B 1.63B 1.51B 1.37B 2.58B 173B 2.61B 18.12B 7.11B 90.88B 6.87B 6.73B 290B | 1.38B 1.23B 1.14B 1.03B 1.94B 130B 1.97B 13.66B 5.36B 68.49B 5.18B 5.07B 218B |
| Net income | 340M 303M 280M 254M 478M 32.06B 483M 3.36B 1.32B 16.85B 1.27B 1.25B 53.69B | -6.15M -5.48M -5.07M -4.59M -8.65M -580M -8.75M -60.8M -23.86M -305M -23.06M -22.58M -972M |
| Net Debt | -244M -218M -202M -182M -344M -23.05B -348M -2.42B -948M -12.12B -916M -897M -38.61B | -618M -550M -509M -461M -869M -58.28B -879M -6.11B -2.4B -30.63B -2.32B -2.27B -97.61B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
